SavedAdd your journal

Journals / Viral Hepatitis Journal / 2015 / Cilt: 21 - Sayı: 1

Kronik Hepatit B’li Bir Hastada Pegile İnterferon Alfa 2a Tedavisine Bağlı Akut Pankreatit Gelişimi: Olgu Sunumu

Development of Acute Pancreatitis Due to Pegylated Interferon Alpha 2a in a Patient with Chronic Hepatitis B: A Case Report

Şükran KÖSE
Melda TÜRKEN
MEHMET TANRISEV
Gülgün AKKOÇLU
Pages
35–37
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, we present a 50-year-old patient with chronic renal insufficiency and chronic hepatitis B who developed acute pancreatitis during treatment with peg-IFN alpha-2a.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Interferons (IFNs) are immunomodulatory and antiviral agents used in the treatment of chronic hepatitis B and C.
📊
Key Findings & Data:Development of acute pancreatitis is a very rare complication seen during IFN (pegylated or standard) treatment in chronic viral hepatitis.
💡
Conclusion & Impact:In this report, we present a 50-year-old patient with chronic renal insufficiency and chronic hepatitis B who developed acute pancreatitis during treatment with peg-IFN alpha-2a.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Interferons (IFNs) are immunomodulatory and antiviral agents used in the treatment of chronic hepatitis B and C. Development of acute pancreatitis is a very rare complication seen during IFN (pegylated or standard) treatment in chronic viral hepatitis. In this report, we present a 50-year-old patient with chronic renal insufficiency and chronic hepatitis B who developed acute pancreatitis during treatment with peg-IFN alpha-2a.

Özet

İnterferonlar (IFNs) kronik viral hepatit B ve C tedavisinde kullanılan, immünmodülatör ve antiviral etkinliği olan ajanlardır. kronik viral hepatitlerde IFN (pegile veya standart) tedavisi sırasında akut pankreatit gelişmesi çok nadir bir komplikasyondur. Bu raporda kronik hepatit B ve kronik böbrek yetmezlikli, peg-IFN alfa-2a tedavisi ile akut pankreatit gelişen, 50 yaşında bir hastayı sunduk.

🔖

Cite This Article

KÖSE, Ş., TÜRKEN, M., TANRISEV, M., AKKOÇLU, G. (2015). Kronik Hepatit B’li Bir Hastada Pegile İnterferon Alfa 2a Tedavisine Bağlı Akut Pankreatit Gelişimi: Olgu Sunumu. Viral Hepatitis Journal, Cilt: 21 - Sayı: 1, 35–37. https://ajindex.com/articles/332698

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Chaudhari S, Park J, Anand BS, Pimstone NR, Dieterich DT, Batash S, et al. Acute pancreatitis associated with interferon and ribavirin therapy in patients with chronic hepatitis C. Dig Dis Sci.2004;49:1000–1006
  2. Russo MW, Fried MW. Side effects of therapy for chronic hepatitis C. Gastroenterology 2003;124:1711-1719
  3. Tahan V, Tahan G, Dane F, Uraz S, Yardim M. Acute pancreatitis attributed to the use of pegylated interferon in a patient with chronic hepatitis C. J Gastrointestin Liver Dis. 2007;16(2):224- 225. 4. kabbaj N, Sentissi S, Guedira MM, Mohammadi M, Benaïssa A, Amrani N. Acute pancreatitis during treatment for chronic viral hepatitis C. Gastroenterol Clin Biol. 2008;32:232-233. 5. kok kF, De Vries RA. Acute pancreatitis in a hepatitis C positive patient following treatment with peginterferon alfa-2b and ribavirin. Ned Tijdschr Geneeskd. 2006;150:681-683
  4. Cecchi E, Forte P, Cini E, Banchelli G, Ferlito C, Mugelli A. Pancreatitis induced by pegylated interferon alfa-2b in a patient affected by chronic hepatitis C. Emerg Med Australas. 2004;16:473-475
  5. Ozdogan O, Tahan V, Cincin A, Imeryuz N, Tozun N. Acute pancreatitis associated to the use of peginterferon. Pancreas. 2007;34:485-487
  6. Vignon Rk, Seddik H, Rouibaa F, En-Nouali H, kabbaj N, Benkirane A. Benkirane Acute pancreatitis during pegylated interferon therapy in a patient with chronic hepatitis B. J Gastrointestin Liver Dis. 2009;18(4):512
  7. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med. 1994;330:1198-1210
  8. Eland IA, Rasch MC, Sturkenboom MJ, Bekkering FC, Brouwer JT, Delwaide J, Belaiche J, Houbiers G, Stricker BH. Acute pancreatitis attributed to the use of interferon alfa-2b. Gastroenterology. 2000;119:230-233
  9. Mallory A, kern F Jr. Drug-induced pancreatitis: a critical review. Gastroenterology. 1980;78:813-820. 12. kim SR, Imoto S, Mita k, Taniguchi M, Sasase N, Muramatsu A, kudo M, kitai S, El-Shamy A, Hotta H, Hayashi Y. Pegylated interferon plus ribavirin combination therapy for chronic hepatitis C with high viral load of serum hepatitis C virus RNA, genotype 1b, discontinued on attaining sustained virological response at week 16 after onset of acute pancreatitis. Digestion. 2009;79(1):36-39
  10. Fernandez-Miranda C, Castellano G, Guijarro C, Fernandez I, Schoebel N, Larumbe S, Gómez-Izquierdo T, del Palacio A. Lipoprotein changes in patients with chronic hepatitis C treated with interferon-alpha. Am J Gastroenterol. 1998;93:1901-1904
  11. Naeem M,